In agreement with our study, a previous report showed that, in a severe herpes simplex encephalitis mouse model, treatment with either Met-RANTES or anti-RANTES mAb decreased leukocyte recruitment into the brain of HSV-1-infected mice [54]. This evidence concerns the gene CCL5 and herpes simplex encephalitis.